No abstract

No abstract

he evaluation and management of chronic pelvic pain in patients with a history of Essure device (Bayer Health-Care Pharmaceuticals Inc, Whippany, New Jersey) insertion have posed many challenges for both clinicians and patients. The availability of high-quality, evidence-based clinical guidance has been limited. We have reviewed the currently available published data, and here provide an overview of takeaways, as well as share our perspective and approach on evaluating and managing chronic pelvic pain in this unique patient population.

No abstract

No abstract